Oppenheimer Starts Verastem (VSTM) at Outperform, Positive on Targeting Cancer Stem Cells Therapy
Go back to Oppenheimer Starts Verastem (VSTM) at Outperform, Positive on Targeting Cancer Stem Cells Therapy| VERASTEM SHS (NASDAQ: VSTM) | Delayed: 6.58 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.58 | 52 Week High | $2.43 | |||
| Open | $6.58 | 52 Week Low | $1.05 | |||
| Day High | $6.58 | P/E | N/A | |||
| Day Low | $6.58 | EPS | $-1.79 | |||
| Volume | 330 | |||||

